Utility of zanamivir for chemoprophylaxis of concomitant influenza A and B in a complex continuing-care population.
Hirji
Z
Z
Department of Microbiology, Toronto Medical Laboratories and the University of Toronto.
O'Grady
S
S
Bonham
J
J
Mak
M
M
Takata-Shewchuk
J
J
Hawkins
K
K
Gardam
M
M
Law
L
L
Mazzulli
T
T
Conly
J
J
D000280:Administration, Inhalation; D000368:Aged; D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D006146:Guanidines; D006801:Humans; D009980:Influenza A virus; D009981:Influenza B virus; D007251:Influenza, Human / Q000517:prevention & control*; D008297:Male; D011714:Pyrans; D012794:Sialic Acids / Q000627:therapeutic use*; D053243:Zanamivir
D000998:Antiviral Agents; D006146:Guanidines; D011714:Pyrans; D012794:Sialic Acids; D053243:Zanamivir